Advertisement

Archives of Gynecology and Obstetrics

, Volume 299, Issue 1, pp 223–227 | Cite as

Risk factors of persistent HPV infection after treatment for high-grade squamous intraepithelial lesion

  • Kyeong A So
  • In Ho Lee
  • Tae Jin Kim
  • Ki Heon LeeEmail author
Gynecologic Oncology
  • 218 Downloads

Abstract

Purpose

To evaluate the risk factors associated with persistent high-risk human papillomavirus (HR HPV) infections in patients undergoing cervical excision for treatment of high-grade squamous intraepithelial lesion (HSIL).

Methods

A retrospective cohort study included 160 patients who underwent cervical excision for treatment of HSIL between January 2014 and December 2014. The clinical characteristics, cervical cytology, and HPV test results were reviewed. Persistent HR HPV infections were identified within 6 months after treatment. The effects of various factors such as patient age, menopausal status, parity, HPV type, and histopathological results on persistent HR HPV infections were assessed using univariate and multivariate analyses.

Results

The mean age of patients was 38.1 ± 11.5 years (range 18‒86 years). Among them 148 (92.5%) had HR HPV infections, and persistent infections after surgical treatment were detected in 48 (32.4%) patients. Univariate logistic regression analysis showed that older age (> 50 years), short follow-up duration (< 3 months), and menopause were associated with persistent HR HPV infections. Multivariate analysis showed that menopausal status was the only significant independent predictor for HR HPV persistence after treatment (odds ratio, 5.08; 95% confidence interval, 1.93–13.36; P = 0.001).

Conclusions

Persistent HR HPV infections were detected in approximately 30% of patients within 6 months after cervical excision for HSIL. Elderly patients with menopause are at increased risk of HR HPV persistence after treatment for HSIL.

Keywords

Cervical intraepithelial neoplasia Conization HPV Menopause 

Notes

Author contributions

KAS manuscript writing. IHL data analysis. TJK manuscript editing. KHL project development/manuscript review.

Funding

The study was not funded.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The Institutional Review Board approved the study. All procedures performed in this study were in accordance with the ethical standards of the institution and with the 1964 Helsinki Declaration and its later amendments. For this type of study, formal consent is not required.

References

  1. 1.
    Ding DC, Hsu HC, Huang RL, Lai HC, Lin CY, Yu MH et al (2008) Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential. Eur J Obstet Gynecol Reprod Biol 140:245–251CrossRefPubMedGoogle Scholar
  2. 2.
    Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M et al (1999) Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180:1415–1423CrossRefPubMedGoogle Scholar
  3. 3.
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRefGoogle Scholar
  4. 4.
    Choi YJ, Park JS (2016) Clinical significance of human papillomavirus genotyping. J Gynecol Oncol 27:e21CrossRefPubMedGoogle Scholar
  5. 5.
    Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS (2008) Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 168:123–137CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632CrossRefGoogle Scholar
  7. 7.
    Chatzistamatiou K, Moysiadis T, Angelis E, Kaufmann A, Skenderi A, Jansen-Duerr P et al (2017) Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study. Arch Gynecol Obstet 295:1247–1257CrossRefPubMedGoogle Scholar
  8. 8.
    Montz FJ (2000) Management of high-grade cervical intraepithelial neoplasia and lowgrade squamous intraepithelial lesion and potential complications. Clin Obstet Gynecol 43:394–409CrossRefPubMedGoogle Scholar
  9. 9.
    Kucera E, Sliutz G, Czerwenka K, Breitenecker G, Leodolter S, Reinthaller A (2001) Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 100:72–76CrossRefPubMedGoogle Scholar
  10. 10.
    Nagai Y, Maehama T, Asato T, Kanazawa K (2000) Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 79:294–299CrossRefPubMedGoogle Scholar
  11. 11.
    Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114–2119CrossRefPubMedGoogle Scholar
  12. 12.
    Kim YT, Lee JM, Hur SY, Cho CH, Kim YT, Kim SC et al (2010) Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer 126:1903–1909CrossRefPubMedGoogle Scholar
  13. 13.
    Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R et al (2012) Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP). Arch Gynecol Obstet 286:1549–1554CrossRefPubMedGoogle Scholar
  14. 14.
    Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS (2008) The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol 108:549–554CrossRefPubMedGoogle Scholar
  15. 15.
    Song SH, Lee JK, Oh MJ, Hur JY, Na JY, Park YK et al (2006) Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 101:418–422CrossRefPubMedGoogle Scholar
  16. 16.
    Pirtea L, Grigoraş D, Matusz P, Pirtea M, Moleriu L, Tudor A et al (2016) Human papilloma virus persistence after cone excision in women with cervical high grade squamous intraepithelial lesion: a prospective study. Can J Infect Dis Med Microbiol 2016:3076380CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Fallani MG, Penna C, MarchionniM Bussani C, Pieralli A, Andersson KL et al (2008) Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study. Eur J Gynaecol Oncol 29:378–382PubMedGoogle Scholar
  18. 18.
    Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M et al (2003) Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90:358–365CrossRefPubMedGoogle Scholar
  19. 19.
    Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E et al (2006) Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3. Gynecol Oncol 103:631–636CrossRefPubMedGoogle Scholar
  20. 20.
    Nam K, Chung S, Kim J, Jeon S, Bae D (2009) Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 20:91–95CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Baser E, Ozgu E, Erkilinc S, Togrul C, Caglar M, Gungor T (2014) Risk factors for human papillomavirus persistence among women undergoing cold-knife conization for treatment of high-grade cervical intraepithelial neoplasia. Int J Gynaecol Obstet 125:275–278CrossRefPubMedGoogle Scholar
  22. 22.
    García-Piñeres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I et al (2006) Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 66:11070–11076CrossRefPubMedGoogle Scholar
  23. 23.
    Kang WD, Kim SM (2016) Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2–3) especially in postmenopausal women. Menopause 23:81–86CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Cheil General Hospital & Women’s Healthcare Center, College of MedicineDankook UniversitySeoulRepublic of Korea

Personalised recommendations